Nitin Pai quoted in DW over India’s approval of Covaxin

Nitin Pai was quoted in DW over India’s controversial approval of Covaxin. Nitin stressed that the approval was done for extra-scientific reasons and was therefore likely to be criticized.

He was quoted as saying

It would have been far more honest to admit that there is a strong political imperative to fast-track an indigenous vaccine, and that the regulators have accommodated it while minimizing the risks to the public.

You can read the full article here.